Zeki Kocaata
Senior Director Global Real World Evidence & Health Outcomes Lead Vaccines GlaxoSmithKline
Zeki Kocaata is a global pharmaceutical leader with 10+ years of experience delivering Real-World Evidence and Phase 4 strategies that directly enable market access, pricing optimization, and long-term product success. At GSK, he leads global RWE and health outcomes strategy across vaccines, designing and executing impactful evidence programs from development through launch and lifecycle expansion. He has authored 40+ publications and led 20+ studies that strengthened reimbursement cases, supported policy recommendations, and expanded commercial reach into new markets and patient groups. With a strong foundation in epidemiology, health economics, and causal inference, Zeki is known for translating scientifically rigorous evidence into strategic value for patients, payers, and portfolios alike.
Seminars
- Use RWE to inform study design, feasibility, and decision-making to prevent costly delays and reduce early clinical delays
- Close evidence gaps before launch to secure smoother pricing and reimbursement pathways strengthening HTA readiness
- Deploy targeted RWE to demonstrate real-world value and support confident market entry.
